drugset / Trial / NCT01049984
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the efficacy of rasagiline 1 mg as a first add-on treatment to dopamine agonist therapy in early Parkinson Disease (PD) patients, , not optimally controlled on dopamine agonists as compared to placebo.
Timeline
- Start
- 2009-12
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rasagiline | Small molecule | 1 mg | Oral |